aller au contenu
Evolution-adjusted tumor pathophysiology: the novel language of tumor biology Aperçu de cet ouvrage
FermerAperçu de cet ouvrage
Vérifiant…

Evolution-adjusted tumor pathophysiology: the novel language of tumor biology

Auteur : Albrecht Reichle
Éditeur : Dordrecht ; New York : Springer, ©2013.
Édition/format :   Livre électronique : Document : AnglaisVoir toutes les éditions et les formats
Base de données :WorldCat
Résumé :

Evolution-adjusted Tumor Pathophysiology

Évaluation :

(pas encore évalué) 0 avec des critiques - Soyez le premier.

Sujets
Plus comme ceci

 

Trouver un exemplaire en ligne

Liens vers cet ouvrage

Trouver un exemplaire dans la bibliothèque

&AllPage.SpinnerRetrieving; Recherche de bibliothèques qui possèdent cet ouvrage...

Détails

Genre/forme : Electronic books
Type d’ouvrage : Document, Ressource Internet
Format : Ressource Internet, Fichier informatique
Tous les auteurs / collaborateurs : Albrecht Reichle
ISBN : 9789400768666 9400768664
Numéro OCLC : 852664238
Notes : Includes index.
Description : 1 online resource.
Contenu : Preface. I Introduction. 1. Communication a" evolution a" pathophysiology: An endogenous conjunction a"Instead of an introduction. II Combined modularized therapies for metastatic tumors: Pointing to central problems of communication among 'systems participators' in tumors. 2 Applied systems biology for the control of metastatic cancer: Therapeutic top-down strategy for targeting the tumors' normativity. 3 Targeting the proangiogenic network in angiosarcomas: Biomodulatory therapy.4 Long-term results of combined modularized, immune-modulatory, angiostatic, and antiinflammatory therapy in systemically pre-treated multi-systems Langerhans cell histiocytosis. 5 Redirecting and modulating rationalizations of tumor-immanent normative functions in castration-resistant prostate ancer. III Social engineering: Biomodulation, either endogenously initiated or by implementation of non-normative boundary conditions. 6 Non-hierarchically organized operations in malignancies: Stromal dysfunction induces hematopoetic malignancies. 7 Biomodulatory therapy approaches in renal clear cell carcinoma: A perspective. 8 Proteome analysis identified the PPARc ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction.IV The tumors' normativity: Reconstructing and operationalizing starting points for an evolution theory. 9 The philosophical quest of a cancer cell: Redefining existentialism. 10 The tumor's normativity: Normative structures, action norms and decision maxims as therapeutic targets for tumor therapy. 11 Criticizable claims for the validity of communication acts in biological systems: Therapeutic implications in cancer. V Evolution theory. 12 Evolution theory: Its practical relevance for understanding tumor development and specifying tumor therapy. 13 Modularity, subjectivity, intersubjectivity and normativity: Clinically applicable operative benchmarks.14 Turning upside down the mode of science to emphasize and harness the impact of environmental communicative events. VI From genome- or organ-centric to rationalization-centric systematization of tumors. 15 Purposive-rational tumor therapy: Exploiting the tumor's 'living world' for diversifying, specifying and personalizing tumor therapy. 16 Including rationalizations of tumor-associated normative notions in pathophysiologic considerations: Communication-theoretical implications.VII Reconstruction of tumor-immanent normative functions, structures and decision maxims (hubs). 17 Bridging a diagnostic and therapeutic gap: Selecting, assessing and categorizing tumor-associated normative notions. 18 Personalizing tumor pathophysiology by diagnosing developmental problems in tumors with imaging techniques. 19 Biologic memory: Induction by metronomically administered combined modularized therapy. VIII The tool of rationalizations constituting tumor-associated normative notions: The non-genomic counterpart of the tumor genome and therefore, an important therapeutic target for diversifying palliative care. 20 Diversifying and specifying palliative care for patients with metastatic cancer by therapeutic implementation of non-normative boundary conditions. 21 Targeting a hallmark of cancer: Simultaneous inflammation and tumor control for palliative care in metastatic cancer. IX Novel clinical and pharmaceutical technology for bioengineering tumor response. 22 Combined modularized tumor therapy a" tumor biology a" and prognostic factors: Bioengineering tumor response. X Objectifying the systems objects' subjectivity in biological systems: A novel reification of the scientific picture about the 'objective' world. 23 The systems objects' subjectivity as scientific object. Index.
Responsabilité : Albrecht Reichle, editor.
Plus d’informations :

Critiques

Critiques d’utilisateurs
Récupération des critiques de GoodReads...
Récuperation des critiques DOGObooks…

Tags

Soyez le premier.
Confirmez cette demande

Vous avez peut-être déjà demandé cet ouvrage. Veuillez sélectionner OK si vous voulez poursuivre avec cette demande quand même.

Données liées


<http://www.worldcat.org/oclc/852664238>
library:oclcnum"852664238"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/852664238>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:exampleOfWork<http://worldcat.org/entity/work/id/1401855909>
schema:genre"Electronic books."
schema:inLanguage"en"
schema:name"Evolution-adjusted tumor pathophysiology: the novel language of tumor biology"
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=604820>
schema:url<http://dx.doi.org/10.1007/978-94-007-6866-6>
schema:url
schema:url<http://lib.myilibrary.com?id=518952>
schema:workExample

Content-negotiable representations

Fermer la fenêtre

Veuillez vous identifier dans WorldCat 

Vous n’avez pas de compte? Vous pouvez facilement créer un compte gratuit.